Online versions of scientific journals Current user: guest        
Hide Left Menu
Temporary Collection

Customer support
» support service
» FAQ
» help
Abstract of article
Biophysics

 -  Vol. 50, No. 5, September-October 2005, pp. 704-709 Help

[ Previous / Next Abstract | Issue Contents | Bottom of Page ] Delete from Cart Add to Cart Delete from Collection Add to Collection

Product Price:  30.00 USD;  Product Discount:  0.0%;

Full Text: [PDF (220Kb)] |  
 
Sarcomeric Proteins of the Titin Family Form Amyloids
L. G. Marsagishvili1, M. D. Shpagina1, V. I. Emel'yanenko1, and Z. A. Podlubnaya1,2
1Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow oblast, 142290 Russia
2Pushchino State University, Pushchino, Moscow oblast, 142290 Russia

Received February 1, 2005
Key words: skeletal muscle, X-protein, C-protein, H-protein, amyloids, amyloidoses, Congo red, thioflavine T.

This was the first study to show that skeletal muscle sarcomeric proteins of the titin family (X-, C-, and H-proteins) can form in vitro amyloid aggregates of different types: granular aggregates, protofibrils, helically twisted ribbons, linear fibrils, and bundles of linear fibrils. The amyloid nature of these aggregates was confirmed by electron, polarization, and fluorescence microscopy and by spectral methods. In contrast to other amyloidogenic proteins, the X-, C-, and H-proteins easily form amyloids under mild conditions close to physiological ones with respect to pH, ionic strength, and temperature. Similarly to amyloid fibrils of the  Ab  -peptide and tau protein in Alzheimer's disease, amyloid aggregates formed by the X-, C-, and H-proteins are destroyed by the antibiotic tetracycline. Thus, the new proteins—precursors of amyloids and possible participants of amyloidoses in muscles—were discovered. Further study of in vitro amyloidogenesis of these proteins would help to find approaches to controlling this process in organs and tissues.

References

  1. S. Y. Tan and M. B. Perys, Amyloidosis 25, 403–414 (1994).
  2. V. N. Uversky and A. L. Fink, Biochim. Biophys. Acta 1698, 131–153 (2004).
  3. M. R. N. Krebs, E. H. C. Bromley, and A. M. Donald, J. Struct. Biol. 149, 30–37 (2005).
  4. W. E. Klunk, J. W. Pettergrew, and D. J. Abraham, J. Histochem. Cytochem. 37, 1273–1281 (1989).
  5. H. Naiki, K. Higuchi, M. Hosokawa, and T. Takeda, Anal. Biochem. 177, 244–249 (1989).
  6. H. LeVine III, Protein Sci. 2, 404–410 (1993).
  7. M. Goedert, Nature Rev. Neurosci 2, 492–501 (2001).
  8. C. M. Dobson, Phil. Trans. Roy. Soc., Ser. B 356, 133–145 (2001).
  9. S. B. Prusiner, Proc. Natl. Acad. Sci. USA 95, 13363–13383 (1998).
  10. G. S. Jackson and A. R. Clarke, Curr. Opin. Struct. Biol. 10, 69–74 (2000).
  11. N. A. Freidina, A. A. Orlova, and Z. A. Podlubnaya, Structural Bases of Regulation of Biological Motility, Ed. by G. R. Ivanitskii (Nauka, Moscow, 1980) [in Russian].
  12. P. Bennet, R. Starr, A. Elliot, and G. Offer, J. Mol. Biol. 184, 297–309 (1985).
  13. Z. A. Podlubnaya, Structure and Function of Proteins of Contractile Systems, Ed. by G. P. Pinaev (Nauka, Leningrad, 1987), pp. 71–90 [in Russian].
  14. K. Yamamoto and K. Moss, J. Biol. Chem. 258, 8395–8401 (1983).
  15. R. Starr and G. Offer, J. Mol. Biol. 170, 675–698 (1983).
  16. P. M. Bennet, D. O. Furst, and M. Gautel, Rev. Physiol. Biochem. Pharmacol. 138, 203–234.
  17. I. M. Vikhlyantsev and Z. A. Podlubnaya, Biofizika 48, 499–504 (2003).
  18. G. Offer, C. Moos, and R. Starr, J. Mol. Biol. 74, 653–676 (1973).
  19. J. D. Fritz, D. R. Swartz, and M. L. Greaser, Anal. Biochem. 180, 205–210 (1989).
  20. H. Laemmli, Nature 227, 680–685 (1970).
  21. R. Starr and G. Offer, Methods Enzymol., Part B 85, 130–138 (1982).
  22. C. S. Goldsbury, S. Wirtz, S. Sunderji, et al., J. Struct. Biol. 130, 217–231 (2000).
  23. B. O'Nuallain, A. D. Williams, P. Westermark, and R. Wetzel, J. Biol. Chem. 279, 17490–17499 (2004).
  24. F. Chiti, P. Webster, N. Taddei, et al., Proc. Natl. Acad. Sci. USA 96, 3590–3594 (1999).
  25. J. W. Kelly, Curr. Opin. Struct. Biol. 8, 101–106 (1998).
  26. H. LeVine III, Amyloid 2, 1–6 (1995).
  27. Yu. A. Alekseeva, M. D. Shpigina, I. M. Vikhlyantsev, et al., Horizons of Biophysics: from Theory to Practice, Ed. by G. R. Ivanitskii (Pushchino, 2003), p. 83 [in Russian].
  28. L. G. Marsagishvili, I. M. Vikhlyantsev, M. D. Shpagina, et al., in Proceeding of XVII Winter Youth Scientific School “Prospective Directions of Physicochemical Biology and Biotechnology” (Moscow, 2005), p. 7 [in Russian].
  29. L. Marsagishvili, M. Shpagina, V. Emelyanenko, and Z. Podlubnaya, FEBS Journal 272, 297 (2005).
  30. G. Forloni, L. Colombo, L. Girola, et al., FEBS Lett. 487, 404–407 (2001).


PII: S0006350905050064

[ Previous / Next Abstract | Issue Contents | Top of Page ]